Logo image of LABP

LANDOS BIOPHARMA INC (LABP) Stock Analyst Ratings

NASDAQ:LABP - Nasdaq - US5150692011 - Common Stock - Currency: USD

22.93  +0.13 (+0.58%)

After market: 22.91 -0.02 (-0.09%)

Buy % Consensus

48

ChartMill assigns a Buy % Consensus number of 48% to LABP. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 12.96. This target is -43.46% below the current price.
LABP was analyzed by 8 analysts. The buy percentage consensus is at 48. So analysts seem to be rather neutral about LABP.
In the previous month the buy percentage consensus was at a similar level.
LABP was analyzed by 8 analysts. More opinions would make the average more meaningful.

Related screens

LABP Historical Analyst RatingsLABP Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -37 -33 -29 -25 -21 -17 -13 -9 -5 -1 2 4 6 8 10

Price Target & Forecast

Price Low Median Mean High 22.935.0512.9612.9621.44 - -77.98% -43.46% -43.46% -6.49%

Related screens

LABP Current Analyst RatingLABP Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4
Up and Down Grades
Date Firm Action Rating
2024-04-01 HC Wainwright & Co. Downgrade Buy -> Neutral
2023-01-06 Jefferies Downgrade Hold -> Underperform
2022-11-11 SVB Leerink Maintains Market Perform
2022-08-12 SVB Leerink Maintains Market Perform
2022-08-12 Raymond James Downgrade Outperform -> Market Perform
2022-04-12 Jefferies Downgrade Buy -> Hold
2022-01-03 JP Morgan Maintains Neutral
2021-11-16 SVB Leerink Downgrade Outperform -> Market Perform
2021-10-20 Craig-Hallum Initiate Buy
2021-10-19 HC Wainwright & Co. Initiate Buy
2021-09-23 JonesTrading Initiate Buy
2021-07-30 Raymond James Maintains Outperform
2021-03-01 SVB Leerink Initiate Outperform
2021-03-01 Raymond James Maintains Outperform
2021-03-01 JP Morgan Initiate Neutral
2021-03-01 Jefferies Initiate Buy